In focus · trending topic

NF-kB Inhibitors Therapeutics

1 stories · following the connections

Increasing Prevalence of Cancer to Drive the Pipeline for Nuclear factor-kappa B (NF-kB) Inhibitors Therapeutics Pipeline: P&S Market Research

By Nasdaq OMXFeb 7, 2018, 8:30 AM UTC